Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
1.210
-0.020 (-1.63%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $86.07 million as of March 28, 2025. Its market cap has decreased by -85.47% in one year.
Market Cap
86.07M
Enterprise Value
-156.08M
1-Year Change
-85.47%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $86.07M, a decrease of -89.01%. That is a compound annual growth rate of -47.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 86.07M | -44.42% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.65B |
| UnitedHealth Group | 473.35B |
| Johnson & Johnson | 395.03B |
| AbbVie | 364.09B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 227.77B |
| Merck & Co. | 226.05B |
| AstraZeneca | 225.00B |